Susquehanna International Group
CARM

Susquehanna International Group’s Carisma Therapeutics CARM Stock Holding History

Susquehanna International Group’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-469,200
Closed -$1.37M – 12243
2023
Q4 		$1.37M Sell
469,200
-19,600
-4% -$58.3K ﹤0.01% 6203
2023
Q3 		$2.07M Sell
488,800
-33,700
-6% -$213K ﹤0.01% 5056
2023
Q2 		$4.58M Sell
522,500
-132,300
-20% -$720K ﹤0.01% 3684
2023
Q1 		$2.03M Buy
654,800
+625,160
+2,109% +$5.95M ﹤0.01% 5109
2022
Q4 		$362K Sell
29,640
-6,490
-18% -$68.2K ﹤0.01% 8654
2022
Q3 		$311K Buy
36,130
+18,570
+106% +$253K ﹤0.01% 9710
2022
Q2 		$284K Buy
17,560
+2,920
+20% +$33.4K ﹤0.01% 9712
2022
Q1 		$176K Sell
14,640
-1,920
-12% -$26.8K ﹤0.01% 11388
2021
Q4 		$272K Sell
16,560
-330
-2% -$6.64K ﹤0.01% 10711
2021
Q3 		$268K Sell
16,890
-9,030
-35% -$433K ﹤0.01% 10837
2021
Q2 		$2.4M Sell
25,920
-2,550
-9% -$163K ﹤0.01% 5505
2021
Q1 		$1.48M Buy
+28,470
New +$1.34M ﹤0.01% 6672
2020
Q4 		– Sell
-2,695
Closed -$75K – 11041
2020
Q3 		$75K Buy
2,695
+2,165
+408% +$43.3K ﹤0.01% 10062
2020
Q2 		$8K Buy
+530
New +$7.15K ﹤0.01% 9988
2019
Q4 		– Sell
-680
Closed -$16K – 9751
2019
Q3 		$16K Buy
+680
New +$15.9K ﹤0.01% 9969
2018
Q4 		– Sell
-14,285
Closed -$614K – 8975
2018
Q3 		$614K Buy
14,285
+6,940
+94% +$270K ﹤0.01% 6154
2018
Q2 		$286K Buy
+7,345
New +$324K ﹤0.01% 7931

Other funds holding CARM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TOTUOP
Trustees of The University of Pennsylvania Philaldelphia, Pennsylvania $297M AUM
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group's CARM Position: Q3 2024 in Review

Susquehanna International Group sold out of Carisma Therapeutics (CARM) in Q3 2024, closing a stake of 73,323 shares — an estimated $111K sold.

Susquehanna International Group first reported a position in CARM in Q2 2015 and held it in 26 quarters. The position peaked at $3.61M in Q2 2021. 37 funds tracked by Wall St. Rank hold CARM as of Q3 2024.

  • Susquehanna International Group reported no remaining Carisma Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Susquehanna International Group sold 73,323 Carisma Therapeutics shares in Q3 2024, an estimated $111K.
  • Susquehanna International Group first reported a position in Carisma Therapeutics in Q2 2015 and held it in 26 quarters.
  • Susquehanna International Group's Carisma Therapeutics position peaked at $3.61M in Q2 2021.
  • 37 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.